Left Atrial Appendage Transcatheter Occlusion with AMPLATZER TM Amulet TM Device : Real Life Data with Mid ‐ Term Follow ‐ Up Results

Methods: Sixty consecutive patients who had undergone percutaneous LAA occlusion with AMPLATZERTM AmuletTM device from September 2015 to March 2018 were enrolled. Patients were followed for 21 ± 15 months (median – 20 months, interquartile range – 9 to 27 months). The postprocedural assessment was done at the 1st, 6th, and 12th month. Patients were clinically evaluated, and transesophageal echocardiography was performed at each visit. We evaluated the condition of normality of variables using the Kolmogorov-Smirnov test. P-values < 0.05 were statistically significant.